Peptide Science in Hot Water

Joined
Aug 3, 2018
Messages
2,864


After careful consideration, Peptide Sciences has made the decision to voluntarily shut down operations and discontinue the sale of our research products.

We are deeply grateful for your trust and support.

Thank you for being part of the Peptide Sciences community
 
I wonder why
I’m sure they began going big and too much exposure. They were on regular tv commercials. I mean this type of business. Any FDA, DEA can order as much as they want to began an investigation on a business this big. I think they were better off saying low keyed. I’m sure we will hear more on this. I won’t speculate too much. I’m sure they were not asking their customers for proof that they were purchasing for research ect.
 
Last edited:
Looks at this statement that 1st appeared on their web site:


The Smartest Exit in the Gray Market​


Let’s be direct about what likely happened here, because the industry commentary is dancing around it.

Peptide Sciences built a business that, by all available e-commerce data, generated revenue in the hundreds of millions of dollars over its lifetime. They did this by selling research chemicals in a regulatory gray zone where enforcement was sporadic and penalties were manageable.

Then three things changed simultaneously:

  1. The highest-margin products (GLP-1s) became legally untouchable. New legislation and 50+ warning letters made continued sales of semaglutide, tirzepatide, and retatrutide an invitation to federal prosecution rather than a calculated risk.
  2. The enforcement apparatus escalated from letters to raids. Amino Asylum getting their warehouse raided by the FDA in June 2025 sent a message that the era of “we’ll send you a letter and you’ll ignore it” was over.
  3. The quality facade cracked. Independent testing from Finnrick exposed product quality issues that undermined the brand’s core value proposition: that you were getting pharmaceutical-grade products from a scientifically rigorous supplier.
When you’ve already made your fortune, the remaining inventory isn’t worth the legal exposure, and the competitive moat (brand trust) is eroding, the rational move is obvious. Close the website. Walk away clean. Let someone else be the next Amino Asylum.

As we noted in our initial analysis on X: “Peptide Sciences made a quarter billion and walked away at the top. Why fight the FDA in court for a decade when you can just close the laptop and retire? Smartest exit in the gray market.”

This isn’t a tragedy. It’s a business decision.
 
Looks at this statement that 1st appeared on their web site:


The Smartest Exit in the Gray Market​


Let’s be direct about what likely happened here, because the industry commentary is dancing around it.

Peptide Sciences built a business that, by all available e-commerce data, generated revenue in the hundreds of millions of dollars over its lifetime. They did this by selling research chemicals in a regulatory gray zone where enforcement was sporadic and penalties were manageable.

Then three things changed simultaneously:

  1. The highest-margin products (GLP-1s) became legally untouchable. New legislation and 50+ warning letters made continued sales of semaglutide, tirzepatide, and retatrutide an invitation to federal prosecution rather than a calculated risk.
  2. The enforcement apparatus escalated from letters to raids. Amino Asylum getting their warehouse raided by the FDA in June 2025 sent a message that the era of “we’ll send you a letter and you’ll ignore it” was over.
  3. The quality facade cracked. Independent testing from Finnrick exposed product quality issues that undermined the brand’s core value proposition: that you were getting pharmaceutical-grade products from a scientifically rigorous supplier.
When you’ve already made your fortune, the remaining inventory isn’t worth the legal exposure, and the competitive moat (brand trust) is eroding, the rational move is obvious. Close the website. Walk away clean. Let someone else be the next Amino Asylum.

As we noted in our initial analysis on X: “Peptide Sciences made a quarter billion and walked away at the top. Why fight the FDA in court for a decade when you can just close the laptop and retire? Smartest exit in the gray market.”

This isn’t a tragedy. It’s a business decision.
I
 
Well this is 110% what happen. I did not know they posted this. We just wish they did not advertise on so many platforms. In this type of business never good. It would be like EG going on tv and radio stations advertising about something I knew was boarder line. They could have still been around. But FDA and DEA were already investigating them for years. They were easy for them to investigate

They are great people great owners. If I was going to buy peptides. It would be from our signature brand of products or Peptides Science

. I know for a fact they did their homework. They took correct measures to make sure their products did not degrade once sold to customers. Most of these places can not afford to pay for this type of method.

My hat goes off to them. I just feel. They were doing well and did not need to advertise to that level. They took everyone’s customers except ours. Only because they did their homework

Whenever you are given a cease and desist letter. You pretty much want to take it. Not only attorney fees but fines and penalties add up.
 
It's sad all around but agree this is the best way to go about it by simply closing shop. Hopefully the successor to Peptide Sciences will be more low key as the FDA and DEA are always watching and ready to pounce.

Lessons learned.
 

New Posts

Trending

Back
Top